Pharma

Mar 13 2018

Pharmaceutical Technology, pharmaceutical product development.#Pharmaceutical #product #development


pharmaceutical product development

Pharmaceutical product development

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we’ll assume that you are happy to receive all cookies on this website.

Pharmaceutical product development Pharmaceutical product development

  • Log In

Clinical Trials

LIFNano: can nanotech ‘flip the switch’ to cure multiple sclerosis?

Red sage: could this ancient Chinese herb prevent bone loss?

Nutraceuticals are being held back by regulatory confusion

Cold Chain

Evocalcet faces stiff competition in Japan’s CKD-induced hyperparathyroidism market

Blockchain in pharma: opportunities in the supply chain

Are drug expiration dates fit for purpose?

Diseases

LIFNano: can nanotech ‘flip the switch’ to cure multiple sclerosis?

Evocalcet faces stiff competition in Japan’s CKD-induced hyperparathyroidism market

AstraZeneca’s regulatory submission accepted for Tagrisso

Drug Development

LIFNano: can nanotech ‘flip the switch’ to cure multiple sclerosis?

Pharmaceutical M A deals decline

Pharmaceutical product development

GSK seeks FDA approval for tafenoquine to treat P. vivax malaria

Manufacturing

Boehringer gains EMA approval for Cyltezo, the EU’s third Humira biosimilar

DIY medicines: the anarchic fringe of the drug price debate

Can the UK stay on medicine’s cutting edge?

Market Data

Evocalcet faces stiff competition in Japan’s CKD-induced hyperparathyroidism market

Pharmaceutical M A deals decline

Pharmaceutical product development

EMA validates BMS’ application to widen cancer therapy indication

Technology

DIY medicines: the anarchic fringe of the drug price debate

Trackable pills: big benefits or Big Brother?

Inside CARB-X: can this new model for research fix a broken antibiotics market?

All sections

LIFNano: can nanotech ‘flip the switch’ to cure multiple sclerosis?

Cambridge University spin-out company LIFNano is pioneering a new approach to the treatment of multiple sclerosis (MS) by using nanotechnology.

Red sage: could this ancient Chinese herb prevent bone loss?

DIY medicines: the anarchic fringe of the drug price debate

Inside CARB-X: can this new model for research fix a broken antibiotics market?

NICE’s head of scientific advice on pharma R D in a personalised era

Pharma Technology Focus – Issue 65

Boehringer Ingelheim’s Fremont Manufacturing Facility Expansion, California

Latest News

Evocalcet faces stiff competition in Japan’s CKD-induced hyperparathyroidism market

Pharmaceutical M A deals decline

EMA validates BMS’ application to widen cancer therapy indication

Get important industry news and analysis sent to your inbox.

Expert commentary analysis from GlobalData

Evocalcet faces stiff competition in Japan’s CKD-induced hyperparathyroidism market

Pharmaceutical M A deals decline

Boehringer gains EMA approval for Cyltezo, the EU’s third Humira biosimilar

Shingrix: An effective shingles vaccine with huge commercial promise

Pharmaceutical product development Top Selling Healthcare Reports

Most Read

Company releases

Medelpharm s Success at AAPS, San Diego

Hundreds of attendees found their way to the tool in the jungle of formulation at AAPS booth 2003: The STYL’One.

Single-Use Solutions

Pharmaceutical product development

Enterprise Solutions

Changes in the bioprocessing market demand new ways of thinking. How do you scale up to produce the new treatments.

GE Healthcare BioPark Biomanufacturing Campus

Pharmaceutical product development

Pharmaceutical product development

Gerresheimer to Showcase Glass and Plastic Pharmaceutical Packaging Products at CPhI

Gerresheimer has announced it will be showcasing glass and plastic pharmaceutical packaging products that are.

Company whitepapers

Meridian 2017 What s New

Tool for QbD in Tableting

Unlocking the Potential for Efficiency in Downstream Processing

High Performance Packaging

Cadence Acoustic Separator

Your European Resource for Bioequivalence, Bioavailability, and Phase I Studies

The Antibody Dependent Cell Mediated Cytotoxicity

Company A-Z

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Pharmaceutical product development

Projects

Boehringer Ingelheim’s Fremont Manufacturing Facility Expansion, California

Boehringer Ingelheim has broken ground on a $217m expansion of its Fremont facility in California, US.


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *